Dermatologists in India report a rise in hair loss, often telogen effluvium, among GLP-1 weight-loss drug users, particularly those experiencing rapid weight reduction without medical supervision. Nutritional deficiencies and metabolic stress are cited as causes, with a Saudi Arabian study finding 70.4% of users reported shedding.
Japanese scientists at RIKEN Institute and OrganTech identified a "third cell" crucial for fully reconstructing hair follicles, enabling the complete hair-growth cycle in mice. This discovery, published in Biochemical and Biophysical Research Communications, offers a path toward regenerative treatments for baldness and thinning hair.
South Korea's Health Ministry canceled a public debate on covering hair loss treatment under national health insurance after facing criticism for prioritizing it over severe and rare diseases, amid concerns over strained insurance funds.
Middle-aged men face physiological changes impacting metabolism, muscle mass, and hormonal function. Experts recommend increased protein intake, strength training, and mindful skincare. Mental health support and addressing hair loss are also crucial for well-being.
Concerns are rising over the transparency of Donald Trump's medical records after his use of hair loss medication, Propecia, was reportedly omitted from recent records, despite prior documentation and his doctor's statements.
A new report reveals a gap in Donald Trump's medical records regarding his use of finasteride, a hair loss drug. While three doctors confirmed his past use, it's absent from recent reports, raising transparency concerns.
Losing hair during cancer treatment can be devastating, impacting identity and sense of control. Scientists in Japan have made a breakthrough in recreating hair growth cycles in mice, offering hope for reversing hair loss in humans.
LG Household & Health Care announced at the World Hair Congress the discovery of 'Rhamsydil,' a new ingredient that may help alleviate female pattern hair loss and improve hair growth environment without using steroid-derived substances. The company utilized AI in its research.
The rising popularity of GLP-1 weight-loss drugs is driving a surge in demand for hair-care products as users report temporary hair loss. Beauty companies are now innovating and marketing specific treatments to address this growing side effect.
